Wendy Chan
Chief Executive Officer presso LODE GOLD RESOURCES INC.
Patrimonio netto: 42 320 $ in data 31/03/2024
Profilo
Wendy T.
Chan is the founder of Moxie Strategy, Inc., Care Point Medical & Wellness Clinics.
She currently holds the position of Chief Executive Officer & Director at Lode Gold Resources, Inc. since 2023, Independent Director at Riverside Resources, Inc. since 2022, and Director at Mandala Capital, Inc. since 2022.
Previously, she worked as a Business Director at Johnson & Johnson, Janssen Pharmaceuticals, Inc., Aurora Cannabis, Inc., GlaxoSmithKline, Inc., and Janssen, Inc. She also served as a Director at Bc Cancer Foundation and held the position of Business Director at NexGen Hearing.
Additionally, she worked as the Vice President-Corporate Development at Skeena Resources Ltd.
Ms. Chan completed her MBA from McGill University and holds an undergraduate degree from the University of British Columbia.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LODE GOLD RESOURCES INC
0.41% | 04/03/2024 | 900 000 ( 0.41% ) | 21 600 $ | 31/03/2024 |
MANDALA CAPITAL INC
6.15% | 10/02/2023 | 560 000 ( 6.15% ) | 20 720 $ | 31/03/2024 |
RIVERSIDE RESOURCES INC.
-.--% | 17/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Wendy Chan
| Società | Posizione | Inizio |
|---|---|---|
| MANDALA CAPITAL INC. | Director/Board Member | 01/05/2022 |
| RIVERSIDE RESOURCES INC. | Director/Board Member | 01/03/2022 |
| LODE GOLD RESOURCES INC. | Chief Executive Officer | 19/12/2023 |
Precedenti posizioni note di Wendy Chan
| Società | Posizione | Fine |
|---|---|---|
| Bc Cancer Foundation | Director/Board Member | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
NexGen Hearing
 NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Corporate Officer/Principal | - |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Formazione di Wendy Chan
| McGill University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| SKEENA RESOURCES LIMITED | Non-Energy Minerals |
| RIVERSIDE RESOURCES INC. | Non-Energy Minerals |
| AURORA CANNABIS INC. | Process Industries |
| LODE GOLD RESOURCES INC. | Non-Energy Minerals |
| MANDALA CAPITAL INC. | Finance |
| Aziende private | 7 |
|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
| Bc Cancer Foundation | |
NexGen Hearing
NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Health Technology |
| Moxie Strategy, Inc. | |
| Care Point Medical & Wellness Clinics |
- Borsa valori
- Insiders
- Wendy Chan
